BEAM
Price
$17.86
Change
-$0.44 (-2.40%)
Updated
Aug 7 closing price
Capitalization
1.81B
94 days until earnings call
OABI
Price
$1.88
Change
-$0.05 (-2.59%)
Updated
Aug 7, 04:59 PM (EDT)
Capitalization
230.68M
Interact to see
Advertisement

BEAM vs OABI

Header iconBEAM vs OABI Comparison
Open Charts BEAM vs OABIBanner chart's image
Beam Therapeutics
Price$17.86
Change-$0.44 (-2.40%)
Volume$1.8M
Capitalization1.81B
OmniAb
Price$1.88
Change-$0.05 (-2.59%)
Volume$12.48K
Capitalization230.68M
BEAM vs OABI Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. OABI commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and OABI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (BEAM: $17.86 vs. OABI: $1.88)
Brand notoriety: BEAM and OABI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 80% vs. OABI: 262%
Market capitalization -- BEAM: $1.81B vs. OABI: $230.68M
BEAM [@Biotechnology] is valued at $1.81B. OABI’s [@Biotechnology] market capitalization is $230.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileOABI’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • OABI’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and OABI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while OABI’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 6 bearish.
  • OABI’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than OABI.

Price Growth

BEAM (@Biotechnology) experienced а -9.39% price change this week, while OABI (@Biotechnology) price change was -3.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.81B) has a higher market cap than OABI($231M). BEAM YTD gains are higher at: -27.984 vs. OABI (-45.480). OABI has higher annual earnings (EBITDA): -47.42M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. OABI (43.6M). OABI has less debt than BEAM: OABI (22.5M) vs BEAM (158M). BEAM has higher revenues than OABI: BEAM (63.6M) vs OABI (26.7M).
BEAMOABIBEAM / OABI
Capitalization1.81B231M782%
EBITDA-399.03M-47.42M842%
Gain YTD-27.984-45.48062%
P/E RatioN/AN/A-
Revenue63.6M26.7M238%
Total Cash1.22B43.6M2,798%
Total Debt158M22.5M702%
TECHNICAL ANALYSIS
Technical Analysis
BEAMOABI
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
65%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 2 days ago
56%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
65%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 2 days ago
43%
Advances
ODDS (%)
Bullish Trend 16 days ago
79%
Bullish Trend 3 days ago
68%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 8 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
59%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 2 days ago
40%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JEGRX17.690.11
+0.63%
Janus Henderson Global Sust Eq R
PRMTX169.03N/A
N/A
T. Rowe Price Comm & Tech Investor
HGHYX39.57N/A
N/A
Hartford Healthcare Y
SUVQX12.89N/A
N/A
PGIM Quant Solutions Large-Cap Val R6
APHRX35.35-0.11
-0.31%
Artisan Global Opportunities Instl

OABI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OABI has been loosely correlated with BEAM. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if OABI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OABI
1D Price
Change %
OABI100%
-5.39%
BEAM - OABI
43%
Loosely correlated
-2.14%
ALEC - OABI
40%
Loosely correlated
-8.33%
NTLA - OABI
40%
Loosely correlated
-1.81%
RXRX - OABI
40%
Loosely correlated
-0.90%
CRBU - OABI
39%
Loosely correlated
-7.84%
More